Back to the Future: Cloning Human Stem Cells [VIDEO]
By Al Jazeera,
Al Jazeera
| 05. 17. 2013
In a major step forward in science, biologists have finally managed to create human stem cells through cloning. Some say it advances the search for medical treatments, others call for new laws to prevent cloning for ethical reasons.
The first attempt at cloning took place over fifteen years ago. In 1996, Dolly the sheep was the first animal to be cloned by scientists in Scotland.
Since then, the process has been carried out on dogs, mice and other animal species. Now, scientists in the US have used similar techniques, which created Dolly, to produce embryos in order to clone human stem cells.
"The technique isn’t new – the results are," reports Al Jazeera's Alan Fisher.
"Microscopic genetic material was taken from an adult cell. It was then inserted into an egg whose own DNA had been removed. This creates human embryonic stem cells, which are capable of becoming any of the more than 200 types of cells that make up a person. That’s important because those cells could be used to treat devastating conditions such as multiple sclerosis, spinal cord...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...